Abstract
THE adrenocorticotrophic hormone is not a potent diabetogenic agent in the intact cat1, in contrast to growth hormone. Its influence on the diabetogenic activity of growth-hormone preparations in the intact cat has now been studied, as briefly reported elsewhere2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reid, E., J. Endocrinol., 7, xxxvi (1951).
Reid, E., Diabetic J. (in the press; abstract of communication to Diabetic Association, July 6, 1951).
Wilhelmi, A. E., personal communication; cf. Wilhelmi, A. E., Fishman, J. B., and Russell, J. A., J. Biol. Chem., 176, 735 (1948).
Cotes, P. M., Reid, E., and Young, F. G., J. Endocrinol., 6, xiv (1949).
Reid, E., J. Endocrinol., 7, 120 (1951).
Engel, F. L., Coggins, W. J., Lynn, W., and Viau, A., Fed. Proc., 10, 39 (1951).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
REID, E. Potentiation by Adrenocorticotrophin of the Diabetogenic Action of Growth-Hormone Preparations. Nature 168, 878–879 (1951). https://doi.org/10.1038/168878b0
Issue Date:
DOI: https://doi.org/10.1038/168878b0
This article is cited by
-
The pituitary growth hormone and metabolic processes
Ergebnisse der Physiologie Biologischen Chemie und Experimentellen Pharmakologie (1957)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
